Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
LFMD
LFMD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LFMD News
LifeMD Executives Allegedly Breached Fiduciary Duties
Jan 28 2026
Globenewswire
Zentalis Pharmaceuticals (ZNTL) Surges 17.65% as Investors Renew Interest
Jan 12 2026
NASDAQ.COM
Novo Nordisk Launches Wegovy Pill with 17% Average Weight Loss Efficacy
Jan 05 2026
Benzinga
LifeMD Expands Collaboration with Novo Nordisk to Enhance Offerings
Jan 05 2026
Yahoo Finance
LifeMD Launches Wegovy for Weight Management at $149/month
Jan 05 2026
NASDAQ.COM
LifeMD Launches Wegovy Oral Medication at $149 Monthly Fee
Jan 05 2026
Globenewswire
GH Research (GHRS) Stock Surges 22.36% Ahead of Key Update
Jan 05 2026
NASDAQ.COM
Novo Nordisk and Eli Lilly Launch Weight-Loss Drugs Targeting $150 Billion Market
Dec 29 2025
Newsfilter
LifeMD Declares $0.5546875 Cash Dividend for Preferred Stockholders
Dec 26 2025
Globenewswire
LifeMD Declares $0.5546875 Cash Dividend for Preferred Stockholders
Dec 26 2025
Newsfilter
Benzinga Market Update: Nvidia, Webull, Netflix, and Tech Stocks Experience Largest Sell-Off Since April
Nov 22 2025
Benzinga
Eli Lilly Set for Over 12% Surge? Check Out 10 Leading Analyst Predictions for Wednesday
Nov 19 2025
Benzinga
HC Wainwright & Co. Reaffirms Buy Rating for LifeMD, Adjusts Price Target to $9
Nov 19 2025
Benzinga
Keybanc Keeps Overweight Rating on LifeMD, Reduces Price Target to $8
Nov 19 2025
Benzinga
Dow Drops More Than 300 Points as Home Depot Reports Disappointing Earnings
Nov 18 2025
Benzinga
Alphabet Set to Surge Over 12%? Check Out 10 Leading Analyst Predictions for Tuesday
Nov 18 2025
Benzinga
Show More News
